Browse > Article
http://dx.doi.org/10.7314/APJCP.2015.16.2.769

Fibulin-5 is a Prognostic Marker that Contributes to Proliferation and Invasion of Human Glioma Cells  

Sheng, Xu-Dong (Department of Neurosurgery, the First Affiliated Hospital of Xi'an Medical College)
Chen, Hu (Department of Neurosurgery, Tang-Du Hospital, Fourth Military Medical University)
Wang, Hui (Department of Neurosurgery, the First Affiliated Hospital of Xi'an Medical College)
Ding, Zhi-Bin (Department of Neurosurgery, the First Affiliated Hospital of Xi'an Medical College)
Xu, Gang-Zhu (Department of Neurosurgery, the First Affiliated Hospital of Xi'an Medical College)
Zhang, Jun-Feng (Department of Neurosurgery, the First Affiliated Hospital of Xi'an Medical College)
Lu, Wen-Chao (Department of Neurosurgery, the First Affiliated Hospital of Xi'an Medical College)
Wu, Tao (Department of Neurosurgery, the First Affiliated Hospital of Xi'an Medical College)
Zhao, Ling (Department of Anesthesiology, the First Affiliated Hospital of Xi'an Medical College)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.16, no.2, 2015 , pp. 769-773 More about this Journal
Abstract
Fibulin-5 has recently been considered as a potential tumor suppressor in human cancers. Several studies have shown that it is down-regulated in a variety of tumor types and inhibits tumor growth and metastasis. This study was aimed to investigate the clinical significance of fibulin-5 in glioma and its role in cell proliferation and invasion. We found that the expression of fibulin-5 in glioma tissues was significantly lower than those in normal brain (NB) tissues. Negative expression was significantly correlated with advanced clinical stage (grade III+IV). Furthermore, Fibulin-5 negative expression was correlated with a shorter overall survival of glioma patients. Multivariate Cox repression analysis indicated that fibulin-5 was an independent factor for predicting overall survival of glioma patients. Overexpression obviously inhibited cell proliferation in U251 and U87 cells. Furthermore, it significantly reduced the number of migrating and invading glioma cells. In conclusion, impaired expression of fibulin-5 is correlated with the advanced tumor stage in glioma. Otherwise, Fibulin-5 is an independent prognostic marker for predicting overall survival of glioma patients. Mechanistically, it may function as a tumor suppressor via inhibiting cell proliferation and invasion in gliomas.
Keywords
Fibulin-5; glioma; prognosis; proliferation; metastasis;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Albig AR, Schiemann WP (2005). Fibulin-5 function during tumorigenesis. Future Oncol, 1, 23-35.   DOI
2 Argraves WS, Greene LM, Cooley MA, et al (2003). Fibulins: physiological and disease perspectives. EMBO Rep, 4, 1127-31.   DOI
3 Brat DJ, Scheithauer BW, Fuller GN, et al (2007). Newly codified glial neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: angiocentric glioma, pilomyxoid astrocytoma and pituicytoma. Brain Pathol, 17, 319-24.   DOI
4 de Vega S, Iwamoto T, Yamada Y (2009). Fibulins: multiple roles in matrix structures and tissue functions. Cell Mol Life Sci, 66, 1890-902.   DOI
5 Gu WT, Gu SX, Shou JJ (2014). Pathway and network analysis in glioma with the partial least squares method. Asian Pac J Cancer Prev, 15, 3145-9.   DOI
6 Hagemann C, Fuchs S, Monoranu CM, et al (2013). Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis. Neuro Oncol, 15, 1696-709.   DOI
7 Hu Z, Ai Q, Xu H, et al (2011). Fibulin-5 is down-regulated in urothelial carcinoma of bladder and inhibits growth and invasion of human bladder cancer cell line 5637. Urol Oncol, 29, 430-5.   DOI
8 Hwang CF, Shiu LY, Su LJ, et al (2013). Oncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosis. PLoS One, 8, 84218.   DOI
9 Li C, Yang W, Zhang J, et al (2014a). SREBP-1 has a prognostic role and contributes to invasion and metastasis in human hepatocellular carcinoma. Int J Mol Sci, 15, 7124-38.   DOI
10 Li F, Xu H, Zeng Y, et al (2012). Overexpression of fibulin-5 in retinal pigment epithelial cells inhibits cell proliferation and migration and downregulates VEGF, CXCR4, and TGFB1 expression in cocultured choroidal endothelial cells. Curr Eye Res, 37, 540-8.   DOI
11 Li PD, Wang XJ, Shan Q, et al (2014b). Evaluation of TAZ expression and its effect on tumor invasion and metastasis in human glioma. Asian Pac J Trop Med, 7, 757-60.   DOI
12 Nakamura T, Lozano PR, Ikeda Y, et al (2002). Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature, 415, 171-5.   DOI
13 Noda K, Dabovic B, Takagi K, et al (2013). Latent TGF-beta binding protein 4 promotes elastic fiber assembly by interacting with fibulin-5. Proc Natl Acad Sci USA, 110, 2852-7.   DOI
14 Ohara H, Akatsuka S, Nagai H, et al (2011). Stage-specific roles of fibulin-5 during oxidative stress-induced renal carcinogenesis in rats. Free Radic Res, 45, 211-20.   DOI
15 Papke CL, Yanagisawa H (2014). Fibulin-4 and fibulin-5 in elastogenesis and beyond: Insights from mouse and human studies. Matrix Biol, 37, 142-9.   DOI
16 Schiemann WP, Blobe GC, Kalume DE, et al (2002). Contextspecific effects of fibulin-5 (DANCE/EVEC) on cell proliferation, motility, and invasion. Fibulin-5 is induced by transforming growth factor-beta and affects protein kinase cascades. J Biol Chem, 277, 27367-77.   DOI
17 Tu K, Dou C, Zheng X, et al (2014). Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. BMC Cancer, 14, 938.   DOI
18 Wlazlinski A, Engers R, Hoffmann MJ, et al (2007). Downregulation of several fibulin genes in prostate cancer. Prostate, 67, 1770-80.   DOI
19 Yanagisawa H, Schluterman MK, Brekken RA (2009). Fibulin-5, an integrin-binding matricellular protein: its function in development and disease. J Cell Commun Signal, 3, 337-47.   DOI
20 Xiao W, Zhou S, Xu H, et al (2013). Nogo-B promotes the epithelial-mesenchymal transition in HeLa cervical cancer cells via Fibulin-5. Oncol Rep, 29, 109-16.